0001181431-14-006553.txt : 20140212
0001181431-14-006553.hdr.sgml : 20140212
20140212173425
ACCESSION NUMBER: 0001181431-14-006553
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140211
FILED AS OF DATE: 20140212
DATE AS OF CHANGE: 20140212
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDIVATION, INC.
CENTRAL INDEX KEY: 0001011835
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133863260
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 525 MARKET STREET
STREET 2: 36TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
BUSINESS PHONE: 415-543-3470
MAIL ADDRESS:
STREET 1: 525 MARKET STREET
STREET 2: 36TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
FORMER COMPANY:
FORMER CONFORMED NAME: ORION ACQUISITION CORP II
DATE OF NAME CHANGE: 19960408
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Machado Clarence Patrick
CENTRAL INDEX KEY: 0001311210
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32836
FILM NUMBER: 14601647
MAIL ADDRESS:
STREET 1: 201 SPEAR STREET, 3RD FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
4
1
rrd402211.xml
2/11/14 EXERCISE AND SALE
X0306
4
2014-02-11
0
0001011835
MEDIVATION, INC.
MDVN
0001311210
Machado Clarence Patrick
C/O MEDIVATION, INC.
525 MARKET ST., 36TH FLOOR
SAN FRANCISCO
CA
94105
0
1
0
0
Chief Business Officer and CFO
Common Stock
2014-02-11
4
M
0
40000
10.585
A
70830
D
Common Stock
2014-02-11
4
S
0
4500
79.73
D
66330
D
Common Stock
2014-02-11
4
S
0
22200
80.66
D
44130
D
Common Stock
2014-02-11
4
S
0
13300
81.48
D
30830
D
Stock Option (Right to Buy)
10.585
2014-02-11
4
M
0
40000
0.00
D
2017-10-01
Common Stock
40000
47294
D
Shares sold pursuant to a 10b5-1 Plan.
The shares were sold at prices ranging from $79.12 to $80.095. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $80.13 to $81.12. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $81.1375 to $82.0222. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Fully vested.
/s/ Jennifer J. Rhodes, Attorney-in-fact
2014-02-12